Adaptive radiotherapy in prostate cancer: when and why?

被引：0
|
作者：
Muelas, R. [1 ]
Garcia, R. [2 ]
Vidueira, L. [2 ]
Bonaque, J. [2 ]
Conde, A. [1 ]
Ferrer, C. [1 ]
机构：
[1] Consorcio Hosp Prov Castellon, Oncol Radioterap, Castellon de La Plana, Spain
[2] Consorcio Hosp Prov Castellon, Radiofis & Protecc Radiol, Castellon de La Plana, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2017年 / 123卷
关键词：
D O I：
10.1016/S0167-8140(17)32198-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1666
引用
收藏
页码：S906 / S907
页数：2
相关论文
共 50 条
  • [21] Techniques for adaptive prostate radiotherapy
    McVicar, Nevin
    Popescu, I. Antoniu
    Heath, Emily
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2016, 32 (03): : 492 - 498
  • [22] Postoperative Radiotherapy in Locally Advanced Prostate Cancer: A Question of Who and When
    Wallis, Christopher J. D.
    Satkunasivam, Raj
    Nam, Robert K.
    EUROPEAN UROLOGY, 2017, 71 (06) : 894 - 895
  • [23] Switching from active surveillance to treatment in prostate cancer - why and when?
    Ng, M. Y.
    Begum, S.
    Huang, H. H.
    Lau, K. O. W.
    Lee, L. S.
    BJU INTERNATIONAL, 2017, 119 : 36 - 36
  • [24] Prostate Cancer Imaging: What, Why, and When (CME Credit Available)
    Figueiras, Garcia R.
    Vilanova, J.
    Patel, S.
    Caamano, Gomez A.
    Gonzalez, Baleato S.
    Martin, Villalba C.
    Bermudez, A.
    Padhani, A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 192 (05)
  • [25] PSMA-PET/CT imaging in prostate cancer: why and when
    Francesco Ceci
    Stefano Fanti
    Clinical and Translational Imaging, 2019, 7 : 377 - 379
  • [26] PSMA-PET/CT imaging in prostate cancer: why and when
    Ceci, Francesco
    Fanti, Stefano
    CLINICAL AND TRANSLATIONAL IMAGING, 2019, 7 (06) : 377 - 379
  • [27] Metastasis-Directed Therapy In Prostate Cancer: Why, When, and How?
    Phillips, Ryan M.
    Deek, Matthew P.
    Deweese, Theodore L.
    Tran, Phuoc T.
    ONCOLOGY-NEW YORK, 2019, 33 (10): : 394 - 399
  • [28] Image guided radiation therapy for prostate cancer; how, when and why?
    Escande, A.
    Supiot, S.
    CANCER RADIOTHERAPIE, 2018, 22 (6-7): : 586 - 592
  • [29] Pelvic lymph node irradiation for prostate cancer: Who, why, and when?
    Wang, Dian
    Lawton, Colleen
    SEMINARS IN RADIATION ONCOLOGY, 2008, 18 (01) : 35 - 40
  • [30] Characterizing the Wnt Pathway in Advanced Prostate Cancer: When, Why, and How
    Pal, Sumanta K.
    Swami, Umang
    Agarwal, Neeraj
    EUROPEAN UROLOGY, 2020, 77 (01) : 22 - 23
12345